BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7454 related articles for article (PubMed ID: 127818)

  • 1. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.
    Waldman SR; Roth JA; Kern DH; Pilch YH
    J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivo.
    Waldman SR; Roth JA; Silverstein M; Veltman LL; Pilch YH
    J Lab Clin Med; 1975 Dec; 86(6):938-49. PubMed ID: 1194758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro tests of cellular immunity in man.
    Herberman RB
    Invest Cell Pathol; 1978; 1(3):227-48. PubMed ID: 160405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.
    Roth JA; Golub SH; Grimm EA; Eilber FR; Morton DL
    Surgery; 1976 Jan; 79(1):46-51. PubMed ID: 128842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte responses to phytohaemagglutinin: age-related effects.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1976 Oct; 31(4):583-7. PubMed ID: 1086285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases.
    Mawas C; Sasportes M; Charmot D; Christen Y; Dausset J
    Clin Exp Immunol; 1975 Apr; 20(1):83-92. PubMed ID: 128428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T and B lymphocytes in malignant melanoma patients.
    Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
    Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
    Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
    Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of continuous-flow blood separator leucophoresis on in vitro functions of human lymphocytes.
    Siewertsen HC; Peter HH; Kalden JR; Wysk J; Eckert G; Oehl S; Schäfer UW; Deicher H
    Clin Exp Immunol; 1978 Jun; 32(3):381-6. PubMed ID: 688693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC; Gross TG; Varney ML; Heimann DG; Reed EC; Kessinger A; Talmadge JE
    Bone Marrow Transplant; 1996 Jul; 18(1):53-61. PubMed ID: 8831996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of the cell separator in the treatment of leukemia].
    Höcker P; Pittermann E; Gobets M; Pawlowsky J; Flegel U; Stacher A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(3):283-94. PubMed ID: 52575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells.
    Novogrodsky A; Stenzel KH; Rubin AL
    J Immunol; 1977 Mar; 118(3):852-7. PubMed ID: 191527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
    Braun DP; Harris JE
    J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
    Lee YT
    Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
    Silverman NA; Alexander JC; Potvin C; Chretien PB
    Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 373.